Autologous Matrix-Induced Chondrogenesis (AMIC)

A Global Market Trends Report

TBR10423

  • PUBLISHED: MAY 2024
  • EDITION: 7
  • TABLES: 67
  • REGIONS: 30
  • SEGMENTS: 5
  • PAGES: 139
  • PRICE: US$ 1950
  • TBR10423
  • JOIN OUR PANEL

  

HIGHLIGHTS & REPORT INDEX

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Reach $278 Million by 2030
The global market for Autologous Matrix-Induced Chondrogenesis (AMIC) estimated at US$164.4 Million in the year 2023, is expected to reach US$278 Million by 2030, growing at a CAGR of 6.8% over the period 2023-2030. Collagen, one of the segments analyzed in the report, is expected to record 6.6% CAGR and reach US$158.8 Million by the end of the analysis period. Growth in the Hyaluronic Acid segment is estimated at 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $52.8 Million, While China is Forecast to Grow at 8.6% CAGR
The Autologous Matrix-Induced Chondrogenesis (AMIC) market in the U.S. is estimated at US$52.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$26.1 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 6.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

SELECT PLAYERS

Anika Therapeutics, Inc.; Arthro Kinetics Biotechnology GmbH; B. Braun Melsungen; CONMED Corporation; Geistlich Pharma AG; JRI Orthopaedics Ltd.; Matricel GmbH; Vericel Corporation; Zimmer Biomet Holdings, Inc.

SEGMENTS

» Material (Collagen, Hyaluronic Acid, Polyethylene Glycol (PEG), Polylactic-Co-Glycolic Acid (PGLA), Other Materials)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

ASK US QUERIES

No matter the hour, we’re here to help.

CONTACT US
Scroll